Gordon M. Saul

Gordon M. Saul

Directeur/Membre du Conseil chez
Stanford Byers Center for Biodesign
Health Technology
Consumer Services
Finance

Profil

Mr. Gordon M.
Saul
is Executive-in-Residence at InterWest Partners and Executive-in-Residence at Synvascular, Inc. He is on the Board of Directors at On Demand Therapeutics, Inc. Mr. Saul has extensive years of startup and business development experience in the pharmaceutical and medical device areas.
Prior to joining InterWest in 2003, he was a co-founder, board member and senior vice president of business development and marketing for PowderJect Pharmaceuticals, a publicly traded drug delivery company acquired by Chiron Corporation in 2003.
Prior to PowderJect, he held business development roles at ALZA Corporation and Advanced Cardiovascular Systems, a division of Guidant Corp.
He has also worked in Japan in the financial services industry and in management consulting for The Boston Consulting Group.
Mr. Saul received an A.B. in engineering sciences from Dartmouth College and an M.B.A. from Stanford University.

Postes actifs de Gordon M. Saul

SociétésPosteDébut
Directeur/Membre du Conseil -

Anciens postes connus de Gordon M. Saul

SociétésPosteFin
Corporate Officer/Principal -
Corporate Officer/Principal -
Directeur/Membre du Conseil -
ALZA CORPORATION Corporate Officer/Principal -
Directeur/Membre du Conseil -
Voir l'expérience en détail de Gordon M. Saul

Formation de Gordon M. Saul

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

  1. Bourse
  2. Insiders
  3. Gordon M. Saul
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT